Free Trial

Revvity, Inc. (NYSE:RVTY) Shares Acquired by PNC Financial Services Group Inc.

Revvity logo with Medical background
Remove Ads

PNC Financial Services Group Inc. lifted its holdings in Revvity, Inc. (NYSE:RVTY - Free Report) by 15.7% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 33,635 shares of the company's stock after purchasing an additional 4,576 shares during the period. PNC Financial Services Group Inc.'s holdings in Revvity were worth $3,754,000 at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in RVTY. Principal Financial Group Inc. grew its stake in Revvity by 3.1% during the 3rd quarter. Principal Financial Group Inc. now owns 141,871 shares of the company's stock worth $18,124,000 after purchasing an additional 4,263 shares in the last quarter. Venturi Wealth Management LLC boosted its stake in shares of Revvity by 258.1% in the 3rd quarter. Venturi Wealth Management LLC now owns 881 shares of the company's stock valued at $113,000 after buying an additional 635 shares during the period. Sumitomo Mitsui Trust Group Inc. grew its position in shares of Revvity by 3.3% during the third quarter. Sumitomo Mitsui Trust Group Inc. now owns 299,723 shares of the company's stock worth $38,290,000 after buying an additional 9,473 shares in the last quarter. Victory Capital Management Inc. increased its stake in shares of Revvity by 4.5% during the third quarter. Victory Capital Management Inc. now owns 59,860 shares of the company's stock worth $7,647,000 after buying an additional 2,582 shares during the period. Finally, Bretton Capital Management LLC acquired a new stake in Revvity in the third quarter valued at approximately $1,405,000. 86.65% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other Revvity news, insider Joel S. Goldberg sold 15,170 shares of the company's stock in a transaction dated Thursday, January 30th. The shares were sold at an average price of $126.73, for a total transaction of $1,922,494.10. Following the transaction, the insider now directly owns 33,400 shares in the company, valued at approximately $4,232,782. This represents a 31.23 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, insider Tajinder S. Vohra sold 5,492 shares of the company's stock in a transaction that occurred on Tuesday, January 7th. The stock was sold at an average price of $116.81, for a total value of $641,520.52. Following the completion of the sale, the insider now owns 19,652 shares in the company, valued at approximately $2,295,550.12. This represents a 21.84 % decrease in their position. The disclosure for this sale can be found here. 0.60% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

Several analysts recently weighed in on the stock. Sanford C. Bernstein cut shares of Revvity from an "outperform" rating to a "market perform" rating and set a $130.00 target price on the stock. in a report on Friday, January 10th. KeyCorp raised their price objective on shares of Revvity from $132.00 to $145.00 and gave the company an "overweight" rating in a report on Monday, February 3rd. Barclays raised their price target on Revvity from $135.00 to $140.00 and gave the company an "overweight" rating in a research note on Monday, February 3rd. Bank of America upgraded Revvity from a "neutral" rating to a "buy" rating and set a $138.00 price target on the stock in a research note on Friday, December 13th. Finally, Raymond James reissued an "outperform" rating and set a $145.00 target price (up previously from $140.00) on shares of Revvity in a research report on Monday, February 3rd. Four research analysts have rated the stock with a hold rating, eight have assigned a buy rating and one has given a strong buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $136.25.

Remove Ads

Get Our Latest Stock Report on RVTY

Revvity Trading Down 1.1 %

NYSE:RVTY opened at $110.29 on Friday. The company has a current ratio of 3.60, a quick ratio of 3.03 and a debt-to-equity ratio of 0.41. The firm has a market cap of $13.25 billion, a P/E ratio of 49.91, a PEG ratio of 3.82 and a beta of 1.06. The stock's 50 day simple moving average is $117.04 and its 200-day simple moving average is $118.04. Revvity, Inc. has a 12-month low of $97.32 and a 12-month high of $129.50.

Revvity (NYSE:RVTY - Get Free Report) last issued its quarterly earnings results on Friday, January 31st. The company reported $1.42 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.37 by $0.05. Revvity had a net margin of 9.81% and a return on equity of 7.68%. During the same quarter last year, the business earned $1.25 EPS. Equities analysts anticipate that Revvity, Inc. will post 4.94 EPS for the current year.

Revvity Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, May 9th. Shareholders of record on Friday, April 18th will be given a dividend of $0.07 per share. This represents a $0.28 annualized dividend and a yield of 0.25%. The ex-dividend date of this dividend is Thursday, April 17th. Revvity's payout ratio is 12.67%.

Revvity Company Profile

(Free Report)

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.

Featured Stories

Want to see what other hedge funds are holding RVTY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Revvity, Inc. (NYSE:RVTY - Free Report).

Institutional Ownership by Quarter for Revvity (NYSE:RVTY)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Revvity Right Now?

Before you consider Revvity, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Revvity wasn't on the list.

While Revvity currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Will Tesla’s Robot Future Save Its Falling Stock?

Will Tesla’s Robot Future Save Its Falling Stock?

Tesla’s Future Is Robots, Not EVs? Renowned tech expert Jeff Brown shares why he believes Tesla’s biggest business will be robotics, not electric vehicles.

Related Videos

NVIDIA’s Dip Is a Gift—Here’s Why It Won’t Last
Is There Still Money in AI? How to Invest in the Next Big Wave
Tesla Sinks on Musk Drama—Bounce or Bigger Crash?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads